hearing

135II.Background of theTh was incorporated in - IJIt has a Board of Directors of sixmembers, one of whom i who acts as Executive CDirector of the Fund. it has solicited funds from various -individuals to finance a program of basic research in the chemotherapyof cancer, asthma, hypertension, psychosomatic. disorders and otherchrbnic diseases. Since 1951 Q ha-co-operated.with. the__..Chemical Division of TSS and acted smoothly and efficiently, both asa cut-out for dealing with contractors in the fields of covert chemicaland biological warfare, and as a prime contractor for certain areas ofbiological research. Projects presently being handled for the Agencyby the Fund are administered under the controls and procedurespreviously approved for MKULTRA.III.Background ofis internationally known as ain the field of41gliPresearch and is - CIn thbepast nas eenassociated ina research capacity with both the '3-1MARISg l Du-ing the war l it served as av - cin the Bureau of Medicine and Surgery in the Navy. Since then he-hasmaintained a consulting relationship to the Navy medical research program.: is TOP SECRET cleared and witting of Agency - C.sponsorship of-the programs carried out by the Fund as are two othermembers of the Fund's Board of Directors.IV. Fund. -eactively engaged in aT campaign to raise fundsor toe purpose of erecting a new clinical research wing on the existingThe research wing will cmsist of a - I?building six stories high, 320 feet long and 50 feet wide. Two-thirdsof the space wvill be research laboratories and offices while 100research beds will occupy the remainder. partici- rpation in the fund-raising campaign outlined below will result in hishaving control of one-sixth of the total space in addition to the baseto:-..r!d).i of: 187C75opS.:J::-: 1S77 . Copy # of 2 copies